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Functionally Distinct Isoforms of STAT5
Are Generated by Protein Processing
Mohammad Azam, Carolyn Lee, Inga Strehlow, restricted to the development and then subsequent acti-
vation of eosinophils, basophils, and mast cells. In con-and Christian Schindler*
Departments of Medicine and Physiology trast, IL-3 and GM-CSF have significantly broader and
overlapping roles in the growth, differentiation, and acti-and Cellular Biophysics
College of Physicians and Surgeons vation of multiple myeloid lineages (Sachs, 1993). Con-
sistent with their overlapping biological functions, theseColumbia University
New York, New York 10032 cytokines bind a family of closely related receptors
(Goodall et al., 1993; Kitamura et al., 1994). Each recep-
tor consists of a unique ligand-binding a chain and a
common signal-transducing b chain. Once bound by
Summary ligand, this family induces the expression of genes
through the sequential activation of JAK2 and STAT5
The interleukin-3 family of cytokines, which play an (Azam et al., 1995; Mui et al., 1995; Quelle et al., 1994).
important role in the development of myeloid lineages, Upon activation, STAT5 is released from the receptor,
transduce signals through the JAK±STAT pathway. dimerizes, translocates to the nucleus, and binds to a
Previous studies demonstrate that this process entails member of the g activation site (GAS) family of en-
theactivation of four distinct isoforms of STAT5, where hancers. This in turn culminates in the activation of tar-
two shorter isoforms are activated in a distinct popula- get genes (Schindler and Darnell, 1995). Uniquely, the
tion of cells. We now demonstrate that the shorter IL-3 signaling paradigm employs four distinct STAT5
isoforms represent carboxy-terminal truncations. More- isoforms, which are encoded for by the highly homolo-
over, these truncations are not generated by RNA pro- gous Stat5a and Stat5b genes (Azam et al., 1995; Liu et
cessing, but by a specific proteolytic activity. Consis- al., 1995; Mui et al., 1995). Each gene gives rise to both
tent with the notion that truncated STAT5 isoforms a long and a short isoform. Previous studies have shown
transduce distinct signals, they fail to promote the that the short and long isoforms are activated in distinct
activation of several known interleukin-3 target genes. populations of cells (Rothman et al., 1994; Azam et al.,
These studies suggest that the activity of a specific 1995).
protease may play a critical role in defining the biologi- In the current set of studies we demonstrate that the
cal responses transduced by STAT5. short isoforms are missing the 70- to 80-most carboxy-
terminal amino acids, which have been reported to en-
code the transcriptional activation domain of STAT5Introduction
(Moriggl et al., 1996; Mui et al., 1996). Consistent with
this observation, cells in which the truncated isoformsThe ability of the JAK±STAT pathway to transduce high-
of STAT5 are activated fail to induce several IL-3 targetfidelity signals in response to cytokines was first eluci-
genes. Moreover, these truncated isoforms appear todated for the interferons (Schindler et al., 1992; Schindler
be generated by a STAT5-cleaving protease, the activityand Darnell, 1995). JAKs are receptor-associated tyro-
of which is limited to a distinct population of cells. Thesesine kinases, and STATs (signal transducers and activa-
observations suggest that the generation and subse-tors of transcription) are cytoplasmic transcription fac-
quent activation of carboxy-terminally truncated iso-tors that are activated by JAKs. Studies on other
forms of STAT5 may account for the phenotypically dis-cytokines, including members of the interleukin-3 (IL-3)
tinct responses some cells exhibit to members of thefamily (IL-3, IL-5, and granulocyte/macrophage colony-
IL-3 family of ligands.stimulating factor [GM-CSF] [Goodall et al., 1993; Miya-
jima et al., 1993]) have led to the identification of addi-
tional JAKs and STATs (Schindler and Darnell, 1995). Results
These STATs encode a number of highly conserved do-
mains that contribute to the transduction of ligand-spe- Structural Analysis of the Truncated
Isoforms of STAT5cific signals (Schindler and Darnell, 1995; Gupta et al.,
1996). In contrast, the divergent carboxy termini appear We have previously described two types of DNA-binding
complexes induced by members of the IL-3 family ofto encode a transcription activation domain (MuÈ ller et
al., 1993; Bhattacharya et al., 1996; Mui et al., 1996; cytokines (Azam et al., 1995; Rothman et al., 1994). In
two cell lines that appear to represent an earlier stageQureshi et al., 1996). Consistent with these observa-
tions, functionally distinct carboxy-terminally truncated of myeloid development, DA-3 and FDC-P1 (Miura et al.,
1991; Bourette et al., 1995), a distinct, faster-migratingSTAT isoforms have been reported. For example, natu-
rally occurring truncated STAT1 and STAT3 bind DNA DNA-binding complex, STF-IL3a, is activated (Azam et
al., 1995). STF-IL3a is also activated in another myeloidbut fail to activate transcription as independent factors
(MuÈ ller et al., 1993; Caldenhoven et al., 1996). cell line, 32Dc1, after stimulation with IL-3 (Figure 1, lane
4). Moreover, a differentiated subline of 32D that exhibitsThe IL-3 family of cytokines have been shown to play
an important role in the maturation, proliferation, and early erythroid features (Migliaccio et al., 1989) activates
a different and more slowly migrating complex in re-activation of myeloid lineages. Of this group, the spec-
trum of activity of IL-5 appears to be predominantly sponse to IL-3 or erythropoietin (Rothman et al., 1994).
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Figure 1. The Components of STF-IL3a Are
Not Recognized by Carboxy-Terminal STAT5a-
and STAT5b-Specific Antibodies
Nuclear extracts, prepared from GM-CSF±
stimulated TF-1 cells and IL-3±stimulated
32Dc1, DA-3, Ba/F3, and FdTrk cells were
incubated with antisera and evaluated by
EMSA with an IRF-1 GAS probe. The extracts
were either incubated in nonimmune serum
(Pre; lanes 1 and 4±6), St5aC15 (lane 2), St5bC24
(lane 3), or a combination of St5aC15 and
St5bC24 (STAT5L; lanes 9, 11, and 13). Extracts
prepared from unstimulated (U) cells (lanes
15±19) are shown as controls. The mobility of
STF-IL3a and STF-IL3b is indicated in the left
margin.
This complex is referred to as STF-IL3b and has been STAT5a homodimer and that the STAT5a±STAT5b heter-
odimer has an intermediate mobility (Figure 2C).shown to be activated by IL-3, IL-5, and GM-CSF in a
Similar studieswere carried out toevaluate DNA-bind-number of established myeloid cell lines with erythroid,
ing complexes induced by IL-3 in several murine cellmonocytic, or mast cell±like features (Azam et al., 1995;
lines, employing a pooled set of the STAT5a and STAT5bMui et al., 1995; Pallard et al., 1995). To determine
antibodies (Figure 1). These cell lines included 32Dc1whether these differing complexes might be responsible
(Migliaccio et al., 1989), DA-3 (Miura et al., 1991), FdTrkfor the distinct pattern of responses observed in some
(a derivative of FDC-P1 cells [Isfort et al., 1988; Azamof these different populations of cells, we set out to
et al., 1995]), and Ba/F3 (Daley and Baltimore, 1988)identify their components.
cells. Consistent with the studies in GM-CSF±stimulatedIn a previous set of studies we established, through
TF-1 cells, these antibodies effectively ªsupershiftº (i.e.,purification, that STF-IL3a consisted of 77 and 80 kDa
recognize) the components of the STF-IL3b complex inisoforms of STAT5a and STAT5b respectively (Azam et
IL-3±stimulated Ba/F3 cells (lanes 12±14). However, theyal., 1995). However, because the STAT5a and STAT5b
fail to interact with components of STF-IL3a complexescDNAs appeared to encode proteins larger than 77 and
in DA-3 and 32Dc1 cells (see lanes 8±11). Antibodies80 kDa (Azam et al., 1995; Mui et al., 1995) and STF-
that recognize more amino-terminal domains recognizeIL3b consisted of immunologically related 94 and 96
proteins in both complexes (data not shown; Azam et
kDa proteins, we speculated that the Stat5 genes each
al., 1995). These observations indicate that the carboxy
gave rise to a full-length and a shorter isoform (Azam
terminus of STAT5a and STAT5b, present in the 94 and
et al., 1995). To evaluate the structural relationship of
96 kDa components of STF-IL3b, are missing from the
these isoforms, specific antibody and cDNA reagents 77 and 80 kDa isoforms of STAT5a and STAT5b.
were prepared. As shown in Figure 1, antibodies di- To confirm these supershifting results, full-length
rected against the carboxy terminus encoded for by and carboxy- terminally truncated Stat5a and Stat5b
both STAT5a and STAT5b cDNAs recognize distinct cDNA expression constructs were prepared (Figure 3A).
components of the cluster of three bands that constitute Stat5at and Stat5bt were designed to correspond to
STF-IL3b (the GM-CSF±stimulated TF-1 cells extracts two recently described rat cDNAs that encode putative
shown in lanes 1±3 [Azam et al., 1995]). The STAT5a STAT5 isoforms truncated at amino acids 740 (STAT5at
antibody recognizes proteins in the two slower com- [Kazansky et al., 1995]) and 745 (STAT5bt [Ripperger et
plexes, whereas the STAT5b antibody recognizes pro- al., 1995]), respectively.An additional smaller truncation,
teins in the two faster complexes. These observations giving rise to a 714 amino acid STAT5b protein, was
are consistent with transfection studies indicating that generated by introduction of a stop codon at a conve-
nient NsiI endonuclease restriction site (Stat5bNsi). Thethe STAT5b homodimer has a faster mobility than the
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Figure 2. Characterization of Truncated Isoforms of STAT5
(A) Western blot of a panel of recombinant unphosphorylated STAT5 isoforms. Extracts prepared from 293 cells transiently transfected with
full-length STAT5a (lane 1), full-length STAT5b (lane 2), STAT5a truncated at amino acid 740 (STAT5at, lane 4), STAT5b truncated at amino
acid 745 (STAT5bt, lane 5), or STAT5b truncated at amino acid 714 (STAT5bNsi, lane 6) were fractionated by SDS-PAGE and immunoblotted
by a pan-STAT5antibody (Transduction Laboratory). Oligonucleotide precipitations (Azam et al., 1995) of extractsprepared form IL-3±stimulated
Ba/F3 (lane 3) or FdTrk (lane 7) cells are included as controls. Molecular weight markers (in kilodaltons) are indicated in the right margin.
(B) Western blot of a panel of recombinant tyrosine phosphorylated STAT5 isoforms. Extracts prepared from 293 cells transiently transfected
with full-length STAT5a (lane 1), STAT5a truncated at amino acid 740 (STAT5at, lane 2), full-length STAT5b (lane 3), STAT5b truncated at amino
acid 745 (STAT5bt, lane 4), or STAT5b truncated at amino acid 713 (STAT5bNsi, lane 5) were activated by stimulation of a cotransfected
erythropoietin receptor (Klingmueller et al., 1995), fractionated by SDS-PAGE, and immunoblotted with a pan-STAT5 antibody (Transduction
Laboratories). Oligonucleotide precipitations (Azam et al., 1995) of extracts prepared from IL-3±stimulated FdTrk cells are included as a control
for p77 and p80 (lane 6). Molecular weight markers (in kDa) are indicated in the right margin.
(C) EMSA of the recombinant tyrosine phosphorylated STAT5 isoforms. Whole-cell extracts of the transfectants described in (B) were evaluated
by EMSA with an IRF-1 GAS probe. In lane 3, equal volumes of recombinant STAT5a and STAT5b were coincubated with the GAS probe.
Controls include GM-CSF±stimulated TF-1 cells (lane 4) and IL-3±stimulated FdTrk cells (lane 5). Lanes 1±3 represent an approximate 33
exposure compared to lanes 4±8.
corresponding recombinant proteins were expressed in 2C). Consistent with the SDS-PAGE analysis, the rat-
like isoforms migrated more slowly than native p77/p80293 cells and evaluated by immunoblotting. As had been
previously reported, the full-length Stat5a and Stat5b (STF-IL3a), whereas the complex generated by the Nsi
truncation migrated more rapidly. These studies not onlycDNAs gave rise to the predicted 96and 94kDa isoforms
(Figure 2A, lanes 1 and 2). Both Stat5at and Stat5bt provide convincing evidence that the rat-like alternative
RNA products do not give rise to the 77 and 80 kDaencoded proteins that are larger, and Stat5bNsi encoded
one that is smaller in apparent molecular weight than murine isoforms of STAT5 but also confirm that STF-
IL3b consists of full-length isoforms of STAT5a andp77 and p80 (Figure 2A, lanes 4±7).
Since tyrosine phosphorylation can alter the relative STAT5b (Figure 2C, lanes 1±3). In addition, these studies
suggest that the truncation that gives rise to p80 mustmigration of proteins in SDS polyacrylamide gel electro-
phoresis (PAGE) and our preparations of p77 and p80 are occur between amino acids 714 and 745 of STAT5b
and, by inference, between amino acids 709 and 740 oftyrosine phosphorylated, the experiment was repeated
after activation of each of the truncated STAT5 isoforms STAT5a.
through the stimulation of a cotransfected receptor.
Again, both of the ªrat-likeº isoforms migrated more Are the Carboxy-Terminally Truncated Isoforms
Generated by RNA Processing?slowly and the Nsi isoform faster than bona fide p77
and p80 (Figure 2B). The same activated recombinant The preceding structural studies not only determined
that p77 and p80 represent carboxy-terminally trun-STAT5 isoforms were evaluated by electrophoretic mo-
bility shift assay (EMSA) to confirm that they had been cated isoforms of STAT5a and STAT5b but suggested
that they are not generated through the RNA-processingactivated and to evaluate their relative mobility (Figure
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Figure 3. Evaluation of Alternative Stat5
Transcripts by an RNAse Protection Assay
(A) Schematic representation of the carboxy
terminus of STAT5a and STAT5b. The RNAse
protection probes for Stat5a (A1) and for
Stat5b (B1 and B2) are indicated. Tyrosine
phosphorylation sites (Y), stop codons, and
the 39 untranslated region (39 UTR) of Stat5a
and Stat5b are indicated. Hatched bars rep-
resent the coding regions of Stat5a and
Stat5b. Rat5at, Rat5bt, and Nsi represent car-
boxy-terminal truncations. Probes were pre-
pared by subcloning the illustrated fragments
with the 59 restriction site in the coding se-
quence as indicated and a 39 site in the poly
linker.
(B) RNAse protection assay with two Stat5b
probes. Ten micrograms of total RNA, pre-
pared from murine liver, 32D cells, FdTrk
cells, Ba/F3 cells, or tRNA was incubated with
riboprobes B1 and B2; digested with RNAse
T2; and fractionated on a standard sequenc-
ing gel. A b-actin probe served as a loading
control. Molecular weight markers (in base
pairs) and the length of the fully protected B1
and B2 probes are indicated in the right and
left margins, respectively.
(C) RNAse protection assay with a Stat5a
probe. Ten micrograms of total RNAfrom liver
and 32D cells, FdTrk cells, or tRNA was evalu-
ated as described for (B) with probe A1.
Again, a b-actin probe served as a loading
control. Molecular weight markers (in base
pairs) and the length of the fully protected
A1 probe are indicated in the right and left
margins respectively.
event recently reported in another rodent species (Ka- 1995). Intriguingly, both Stat5b probes were fully pro-
zansky et al., 1995; Ripperger et al., 1995). However, tected when incubated with RNA prepared from cells in
because studies on the generation of the truncated iso- which the truncated isoform of STAT5b is found (FdTrk
forms of STAT1 and STAT3 had established a precedent and 32Dc1 cells; see Figs. 3B). Similar results were ob-
for RNA processing (MuÈ ller et al., 1993; Schaefer et al., tained with the Stat5a probe, excluding the existence
1995; Caldenhoven et al., 1996), this possibility was ex- of all but trace amounts of alternative RNA splice prod-
amined more rigorously, through a set of RNAse protec- ucts in these cells. Furthermore, RNAse protections
tion assays. Riboprobes spanning the appropriate car- studies with the more 39 B2 probe indicated that Stat5b
boxy-terminal regions of murine STAT5a and STAT5b full-length transcript is expressed at equivalent levels
were prepared (Figure 3A). One additional carboxy-ter- in each of these cell types.
minal Stat5b riboprobe, B2, was designed to hybridize
only to transcripts encoding the full-length isoform of
Are the Carboxy-Terminally Truncated IsoformsSTAT5b. These riboprobes were incubated with RNA
Generated by Protein Processing?prepared from either murine liver or IL-3±responsive
The lack of evidence for RNA species that could givecells, digested with RNAse T2, and evaluated on a dena-
rise to p77 or p80 provided indirect support for a protein-turing gel. As expected, theB1 probe was fully protected
processing model. In this model, a specific proteasewhen incubated with RNA prepared from Ba/F3 cells
would process p96 and p94 into p77 and p80, respec-but was fully digested when incubated with tRNA (Figure
tively. To evaluate this model, we first needed to estab-3B). Probe B1 (and B2), but not A1, were also fully pro-
lish, as predicted by the RNAse protection studies, thattected in liver, corresponding with previous reports indi-
full-length proteins (p94 and p96) were synthesized incating that STAT5b is the predominant isoform ex-
pressed in liver (Wakao et al., 1994; Ripperger et al., cells in which p77 and p80 are activated. To this end,
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Figure 4. Differential Expression of STAT5 Isoforms in Several Cell Types
(A) Immunoprecipitation of full-length STAT5 isoforms from DA-3 cells. Cytoplasmic (Cyto.) and nuclear extracts (N.E.), prepared from unstimu-
lated (2) and IL-3±stimulated (1) DA-3 cells were immunoprecipitated with carboxy-terminal STAT5a (5a [St5aC15]) and STAT5b (5b [St5bC24])
antibodies, fractionated by SDS-PAGE, and sequentially immunoblotted with antiphosphotyrosine (a-PY, Upstate Biologicals) and pan-STAT5
(a-St5, Transduction Laboratories) antibodies (lane 1±8). Oligonucleotide precipitation of p77 and p80 for a matched set of nuclear IL-
3±stimulated DA-3 extracts are shown as a control (lane 9). Molecular weight markers (in kilodaltons) are indicated in the left margin.
(B) Immunoprecipitation of full-length STAT5 isoforms from Ba/F3 cells. Whole cell extracts (W.C.E), prepared from unstimulated (2) and IL-
3±stimulated (1) Ba/F3 cells, were immunoprecipitated with carboxy-terminal STAT5a (5a [St5aC15]) and STAT5b (5b [St5bC24]) antibodies;
fractionated by SDS-PAGE; and sequentially immunoblotted with antiphosphotyrosine and pan-STAT5 antibodies as in (A) (lane 1±4). Molecular
weight markers (in kilodaltons) are indicated in the left margin.
(C) Western blot of native STAT5 isoforms expressed in IL-3±responsive cells. Extracts were prepared from matched sets of unstimulated
(-) and IL-3±stimulated (1) DA-3, FdTrk, and Ba/F3 cells either by rapidly lysing the cells in hot SDS-PAGE sample loading buffer (SDS lysis,
lanes 2±7) or by conventional protocols (W.C.E., lanes 9±12; or N.E., lanes 13±15). These extracts were fractionated by SDS-PAGE and
sequentially immunoblotted with a pan-STAT5 (a-St5) antibody (lanes 1±18) and St5bC17 (lanes 1±12; Santa Cruz Biotechnology). Controls are
included in lane 1, p77 and p80 from nuclear FdTrk extracts; lane 8, recombinant STAT5b (see legend for Figure 5); lane 16, oligonucleotide
precipitated IL-3±stimulated FdTrk extracts; and p94 (lane 17) and p96 (lane 18) prepared from unstimulated YT cells. Molecular weight markers
(in kilodaltons) are indicated in the left margin.
cytoplasmic and nuclear extracts, prepared from DA-3 become rapidly activated after stimulation with IL-3 in
these cells (Figure 4A, lane 5). However, with the aidcells before and after IL-3 stimulation, were immunopre-
cipitated with the STAT5a and STAT5b carboxy-termi- of p94- and p96-specific antibodies it is possible to
demonstrate that some of the full-length isoforms be-nal±specific antibodies (Figure 4A). As a control, the 77
and 80 kDa STAT5 isoforms were collected from a paral- come activated early after stimulation with IL-3 (Figure
4A, lanes 2 and 4).The recovery of p77 in the STAT5a andlel aliquot of IL-3±stimulated extracts by oligonucleotide
precipitation (Figure 4A, lane 5). Further controls were STAT5b immunoprecipitations suggests that activated
p77 may associate with the full-length isoforms in theprovided by a matched set of immunoprecipitations
from Ba/F3 cells, where p94 and p96 are activated in cytoplasm. A more quantitative EMSA study (data not
shown) confirms the relatively modest (in comparisonresponse to IL-3 (Figure 4B).Both sets of immunoprecip-
itates were fractionated by SDS-PAGE and then sequen- to p77 and p80) activation of p94 and p96 in cytosolic
DA-3 extracts prepared after 5 to 15 min of stimulationtially immunoblotted with antiphosphotyrosine and a
pan-STAT5 antibody. As anticipated, p94 and p96 were with IL-3 but not after longer periods of stimulation.
However, in contrast to what is observed in the controltyrosine phosphorylated in stimulated but not unstimu-
lated Ba/F3 cells (Figure 4B). Reprobing with the pan- Ba/F3 cells, the p94 and p96 activated in DA-3 cells fail
to translocate to the nucleus (Figure 4A, lanes 7 and 9;STAT5 antibody confirmed that the tyrosine-phosphory-
lated and unphosphorylated isoforms of STAT5a (p96) Figure 4C, lanes 14 and 15). Only truncated p77 and p80
are found in these nuclei (Figure 1, lanes 7±11; Figureessentially comigrate (Figure 4B, lanes 1 and 2), whereas
the tyrosine-phosphorylated isoform of STAT5b (p94) 4C [Rothman et al., 1994; Azam et al., 1995]). These
observations not only provide further support for themigrates more slowly than the unphosphorylated form
(Figure 4B, lanes 3 and 4 [Mui et al., 1995]). The detection protein processing model; they also suggest that only
the truncated isoforms have access to the nucleus inof both STAT5b isoforms in stimulated Ba/F3 cells indi-
cates that only about one half of STAT5b is activated these cells.
Next we wanted to determine whether STAT5 pro-after 15 min of IL-3 stimulation (Figure 4B, lane 4).
Evaluation of the extracts prepared from DA-3 cells cessing was a constitutive or dynamic (ligand depen-
dent). The pattern of STAT5 expression was evaluatedprovides an important contrast to the Ba/F3 cells (Figure
4A). As predicted by the protein-processing model, p94 by immunoblotting samples prepared from DA-3, FdTrk,
and Ba/F3 cells either by rapid lysis/denaturation orand p96 are abundantly expressed in unstimulated DA-3
cells. Consistent with previous studies, p77 and p80 by more standard protocols (e.g., whole-cell extracts
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[Rothman et al., 1994] or nuclear extracts [Dignam et tyrosine phosphorylation (i.e., an upward shift in mobil-
ity). Similarly, in Ba/F3 cells there is only modest evi-al., 1983]). The nuclear and whole-cell extracts from IL-
dence for IL-3 dependent activation of p94 (i.e., an up-3±stimulated DA-3 (and FdTrk) cells confirm that trun-
ward shift in mobility) in SDS lysis samples, despite clearcated STAT5 is the major isoform recovered from these
evidence for this in nuclear extracts (Figure 1 and Figurecompartments, consistent with a more dynamic process
4C, lanes 10±11). Although these observations are un-(Figure 4C, lanes 10, 14 and 15). Note that p77 (STAT5a)
able to distinguish clearly between a static or dynamicappears to be more the abundant isoform in these cells.
model of STAT5 processing, they seem to suggest thatParallel studies with nuclear and whole-cell extracts
only the appropriate isoforms localize to a compart-from Ba/F3 cells indicate that only full-length isoforms
ment(s) that is permissive for nuclear translocation. Thisof STAT5 are recovered from these compartments (Fig-
will need to be confirmed by further studies. In addition,ure 4C, lanes 11±13). Again, STAT5a (p96) appears to
these observations indicate that protein processing isbe more abundant. Extracts prepared by the SDS lysis
essentially restricted to DA-3 and FdTrk cells.protocol support a more static process. As anticipated,
p94 and p96 are readily detected in each of the unstimu-
Characterization of STAT5 Protease Activitylated cell types (Figure 4C, lanes 1±6). Truncated STAT5
To find more direct evidence for a protease, a STAT5-isoforms are consistently detected in starved/unstimu-
cleaving assay was established. This entailed the prepa-
lated DA-3 and FdTrk cells (Figure 4C, lanes 2 and 4),
ration of recombinant STAT5b immobilized on an oligo-
suggesting either that truncated STAT5 isoforms have
nucleotide affinity matrix. As shown in Figure 5A, when
a long half-life (i.e., survive through the starvation pe- the STAT5b is eluted from this matrix and fractionated
riod), or that these isoforms are generated constitutively. on SDS-PAGE, the expected major band of 94 kDa is
Ligand induced changes are relatively subtle for all three detected with the STAT5 monoclonal antibody. Consis-
cell types. When DA-3 (factor dependent) and FdTrk tent with the protease model, when this preparation of
(factor independent) cells are stimulated, there appears STAT5b is incubated with a CHAPS extract prepared
to be a modest loss of p94 and a corresponding modest from Ba/F3 cells, only full-length p94 is recovered. How-
increase in p77 (Figure 4C, lanes 3 and 5). Consistent ever, when STAT5b is incubated with a CHAPS extract
with the immunoprecipitation studies (Figure 4A), re- prepared from FdTrk cells (or DA-3 cells; data not
probing with a STAT5b-specific antibody (a-St5C17) indi- shown), it is processed to the appropriate 80 kDa iso-
form. Moreover, this cleavage is fully inhibited by thecates that some of the p94 loss can be attributed to
Figure 5. STAT5-Cleaving Activity Is Present
in Extracts Prepared from FdTrk but Not
Ba/F3 Cells
(A) Recombinant tyrosine-phosphorylated
STAT5b, prepared from insect cells, was col-
lected by oligonucleotide precipitation (lane
1), and incubated (1 hr at 378C) with CHAPS
extracts prepared from FdTrk (lane 2 and 3)
or Ba/F3 (lane 4 and 5) cells in the presence
or absence of PMSF as indicated. Proteins
were recovered by heating in SDS-PAGE
sample buffer, resolved by SDS-PAGE, and
immunoblotted with a pan-STAT5 antibody
(Transduction Laboratories). Molecular weight
markers (in kDa) and the mobility of both iso-
forms of STAT5b (p94 and p80) are indicated
in the left and right margins, respectively.
(B) Partially purified preparations of protease
were assay as described in (A). Three microli-
ters of heparin agarose±fractionated prote-
ase activity (Pr-a) was incubated with 5±10 ml
immobilized STAT5b for 5, 30, and 60 min
(lanes 1±5) at 378C. PMSF (I) was added in
lane 5. In lane 6, a less potent preparation
of protease (Pr-b) was assayed for 30 min.
Controls include lane 1, uncut STAT5b; and
lane 7, IL-3±stimulated FdTrk nuclear extract.
Molecular weight markers (in kilodaltons) and
the mobility of both isoforms of STAT5b (p94
and p80) are indicated in the left and right
margins, respectively.
(C) EMSA to evaluate the specificity of the protease. Extracts were prepared and assayed as described in legend to Figure 1. Lane 1, IL-
6±stimulated HepG2 cells; lane 2, IL-6±stimulated HepG2 cells supershifted with STAT1 carboxy-terminal±specific antibody (Schindler et al.,
1992); lane 3, murine IFNg-stimulated DA-3 cells; lane 4, murine IFNg-stimulated DA-3 cells supershifted with STAT1 carboxy-terminal±specific
antibody; lane 5, 1 ml of IL-6±stimulated HepG2 cells; lane 6, IL-6±stimulated HepG2 cells incubated with 3 ml of heparin agarose fractionated
protease at 378C for 1 hr prior to EMSA; lane 7, 1 ml recombinant STAT5b; and lane 8, recombinant STAT5b incubated with 3 ml of heparin
agarose±fractionated protease at 378C for 1 hr prior to EMSA.
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serine protease inhibitor phenyl-methyl sulfonyl fluoride the other genes remained quiescent (Figure 6A). Since
IL-3 is not an essential growth factor for FdTrk cells(PMSF). Similar studies with partially purified prepara-
tions of the protease confirm the sensitivity to PMSF and WEHI-conditioned media may contain confounding
activities, the experiment was repeated with recombi-(Figure 5B, lane 5) and provide further evidence for the
protease by demonstrating that it cleaves its substrate nant IL-3 in the IL-3±dependent cell line DA-3 (Figure
6B). Again, c-myc, CIS, and OSM were rapidly inducedina time-dependentprocess (Figure 5B, lanes 1±4).Con-
sistent with these kinetic studies, an equivalent volume in Ba/F3 cells, but CIS and OSM failed to be induced
with the kinetics of an immediate early gene. The modestof a cruder preparation of protease has less activity at
30 min (Figure 5B, lane 6). Of a cautionary note, even activation of CIS at 180 min is not consistent with activa-
tion through the JAK±STAT pathway, but rather somethough the major cleavage product with partiallypurified
preparations of protease is bona fide p80, additional secondary pathway. These observations concur with
recently published studies showing that carboxy-termi-smaller bands are generated. We believe that this is due
to overdigestion, since these products appear to be nally truncated STAT5 cDNAs behave as dominant neg-
ative isoforms, actively repressing IL-3±stimulated acti-generated in a dose-dependent manner and there is no
loss of specificity. vation of OSM and CIS (Mui et al., 1996; Wang et al.,
1996). These studies suggest that the naturally trun-Next, both in vivo and in vitro studies were carried
out to evaluate the specificity of the protease activity. cated STAT5 isoforms are functionally distinct and are
likely to contribute to a unique biologic response to IL-3As shown in Figure 5C (lanes 1±4), when DA-3 cells
are stimulated with interferon-g (IFNg), the previously in the cells where they are expressed.
characterized doublet of STAT1 DNA-binding activity is
observed (Rothman et al., 1994). This complex does not
Discussioncontain any carboxy-terminally truncated STAT1, since
it is supershifted as effectively as control STAT1 with a
Recent studies have determined all three members ofSTAT1-, carboxy-terminal±specific antibody. Further-
the IL-3 family transduce signals through the same JAK±more, the DNA-binding activities of STAT1 and STAT3
STAT signaling paradigm. In contrast to other cytokines,are not affected by incubation with a partially purified
the IL-3 family signals through distinct subsets of STAT5preparation of protease (Figure 5C, lanes 5±8). Yet, par-
isoforms. In some cells the 77 and 80 kDa isoforms ofallel studies with preparations of full-length STAT5b
STAT5a and STAT5b are activated and transduce sig-demonstrate the anticipated protease-dependent con-
nals to the nucleus. In other cells the 96 and 94 kDaversion to a faster-migrating DNA-binding complex
isoforms of STAT5a and STAT5b are activated and(STF-IL3a). These studies provide compelling evidence
transduce signals to the nucleus. Studies in several es-for the existence of a serine protease in FdTrk and DA-3
tablished hematopoietic murine cell lines suggest thatcells (data not shown) that rapidly and specifically
the truncated isoforms may be preferentially activatedcleaves full-length STAT5 into a physiologically relevant
in more immature lineages (see above [Rothman et al.,truncated isoform.
1994; Azam et al., 1995; Wang et al., 1996]). However,
this has not been determined in primary cells. To evalu-
ate the possibility that the long and short STAT5 iso-The Carboxy-Terminally Truncated STAT5
Isoforms Are Functionally Distinct forms may be functionally distinct, we initially examined
their structural relationship. These experiments demon-Studies on STAT1, STAT2, and STAT3 indicate that the
carboxy terminus encodes the transcriptional activation strated that p77 and p80 represent carboxy-terminal
truncations of the full-length 96 and 94 kDa isoforms ofdomain (Bhattacharya et al., 1996; Caldenhoven et al.,
1996; MuÈ ller et al., 1993; Qureshi et al., 1996). Moreover, STAT5a and STAT5b.Studies in which stopcodons were
experimentally introduced into the carboxy termini ofcarboxy-terminally truncated isoforms of STAT1 and
STAT3, which retain DNA-binding activity, can behave the Stat5b (and Stat5a) cDNAs indicate that p80 repre-
sents a truncation between amino acids 714 and 745.as dominant negative isoforms, suppressing transcrip-
tion (MuÈ ller et al., 1993; Caldenhoven et al., 1996). These By analogy, p77 appears to represent a truncation of
STAT5a between amino acids 709 and 740 (Figure 3A).observations suggest that the naturally occurring car-
boxy-terminally truncated STAT5 isoforms might simi- Since studies on other STATs have suggested that these
deleted regions may encode a transcriptional activationlarly be defective in the activation of target genes. To
test this, the expression of several IL-3±stimulated im- domain (MuÈ ller et al., 1993; Bhattacharya et al., 1996;
Mikita et al., 1996; Qureshi et al., 1996), we wonderedmediate early genes was evaluated. The panel of imme-
diate early genes included bothbona fide (e.g., cytokine- whether this might explain the distinct biological re-
sponses exhibited by developmentally related lineagesinducible SH2-containing protein [CIS] and oncostatin
M [OSM] genes [Yoshimura et al., 1995, 1996]) and po- to the same ligand (Sachs, 1993). Consistent with this
possibility, we found a direct correlation between thetential (e.g., c-fos, c-myc, and pim-1 [Mui et al., 1996;
Quelle et al., 1996; Wang et al., 1996]) targets of the IL- activation of several IL-3 target genes and the presence
of a STAT5 carboxy terminus. Cells in which the trun-3±stimulated JAK±STAT pathway. As anticipated, North-
ern blotting studies revealed that each of these genes cated isoforms of STAT5 are activated fail to rapidly
induce most of these genes, including those known tois rapidly activated in response to IL-3 in the Ba/F3 cells
(Figure 6A). However, the pattern of gene activation was be activated by the JAK2±STAT5 pathway (CIS and OSM
[Yoshimura et al., 1995; Yoshimura et al., 1996]) andsignificantly different in FdTrk cells. Only c-myc was
activated with kinetics similar to the Ba/F3 cells, while several potentially activated by this pathway (pim-1 and
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Figure 6. Differential Induction of Immediate
Early Genes in Response to IL-3 in Immature
and Mature Cells
(A) Ten micrograms of RNA, recovered from
FdTrk and Ba/F3 stimulated with 10% WEHI-
conditioned medium, for the indicated peri-
ods of time (tm, time in minutes), was fraction-
ated on a formaldehyde gel (Azam et al.,
1995), transferred to a nitrocellulose mem-
brane, and sequentially hybridizedwith radio-
labeled c-myc, c-fos, CIS, pim-1, OSM, and
GAPDH probes as indicated.
(B) Ten micrograms of of RNA, recovered
from DA-3 and Ba/F3 cells stimulated with 10
ng/ml of recombinant IL-3 for the indicated
periods of time, was evaluated as described
in (A) with c-myc, CIS, OSM, and GAPDH
probes as indicated.
c-fos; Sato et al., 1993; Quelle et al., 1996). c-myc, which either this protease is constitutively active or that it re-
sides in a restricted, detergent (CHAPS)±soluble com-is induced in both cell types, is likely to be activated by
partment. An intriguing and potentially related observa-a different more conserved pathway. These functional
tion is that the full-length informs of STAT5 appear tostudies, which assign distinct properties to the trun-
be more difficult to extract from DA-3 and FdTrk cells.cated STAT5 isoforms, are supported by results from
These observations and the determination of when theother groups demonstrating that overexpression of trun-
protease is active are currently under investigation.cated STAT5 isoforms can block the ability of the native
Studies in primary cells awaita more definitive identifica-full-length STAT5 to activate target genes (Mui et al.,
tion of this protease.1995; Wang et al., 1996).
As these studies were being completed, additionalPrevious studies on the carboxy-terminally truncated
albeit indirect support for RNA-processing model wasisoforms of STAT1 and STAT3 have established the
published (Wang et al., 1996). However, the data in theseprecedent that truncated STATs are generated by alter-
studiesare also consistent with an alternative interpreta-native splicing (MuÈ ller et al., 1993; Schaefer et al., 1995;
tion. Results from a PCR-based assay, designed to dem-Yan et al., 1995; Caldenhoven et al., 1996). Evidence
onstrate the presence of a rat-like RNA ªread-throughºthat the truncated isoforms of STAT5 may also be gener-
product in mice, could not distinguish between the pos-ated by RNA processing comes from the recent isolation
sibility of a putative read-through product, a primaryof rat cDNAs encoding isoforms of STAT5 truncated at
transcript, or a DNA template. In addition, an importantamino acids 740 (STAT5a) or 745 (STAT5b) (Kazansky
negative control, RNA prepared from cells expressinget al., 1995; Ripperger et al., 1995). However, our studies
full-length isoforms, was not included.The secondset of
indicate that these rat-like Stat5 cDNAs encode proteins
studies, which entailed the characterization of truncated
that are too large to be p77 and p80. Furthermore,
STAT5 isoforms, were intended to corroborate the re-
RNAse protection studies failed to identify any alterna- verse transcriptase PCR results. However, the trunca-
tive RNA products that might give rise to p77 or p80. tions these authors introduced were at amino acids 713
Rather, they demonstrated that all cells express the full- (STAT5a) and 718 (STAT5b) and not amino acids 740
length transcripts, even those in which p77 and p80 and 745 as predicted by their by their RNA read-through
transduce signals. model. Hence, their observations support the protein-
In the absence of any evidence for RNA processing, processing model by demonstrating that the rat-like
we considered the possibility that the truncated iso- truncations are too large to encode for p77 and p80.
forms of STAT5 are generated by a cell-specific protein- In summary, our efforts to evaluate the truncated iso-
processing event. Supporting this model, all cells exam- forms of STAT5 have determined that they are function-
ined express both full-length Stat5 transcripts and gene ally distinct from the full-length isoforms and that they
products. A subpopulation of cells express the trun- are generated by a unique protein-processing event.
cated isoforms of STAT5 as well. Although the existence The protease that mediates this is PMSF sensitive,
of both full-length and truncated Stat5 gene products STAT5 specific, and cell type specific. The identification
in FdTrk, DA-3 and 32Dc1 cells does not formally ex- of protease activity in several cell lines that are believed
clude RNA processing, it supports the protein-pro- to represent earlier stages in myeloid differentiation (see
above) suggests that this protease may be involved incessing model as well. Further and more compelling
the regulation of lineage-specific STAT5 signaling. Fur-support for the protein-processing model comes from
ther characterization of this protease should provide thethe identification of STAT5-specific carboxy-terminal
reagents required to explore its activity in vivo.cleaving activity. This activity is found only in cells in
which p77 and p80 are expressed and is inhibited by a
Experimental Proceduresserine protease inhibitor. Moreover, it exhibits kinetics
appropriate for a protease. The identification of this ac- Cell Culture
tivity in extracts prepared from both unstimulated or Cell culture reagents were purchased from GIBCO±BRL. HepG2,
DA-3, 32D, TF-1, WEHI, and FdTrk cells were grown as previouslystimulated cells (e.g., FdTrk and DA-3) suggests that
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described (Rothman et al., 1994; Azam et al., 1995; Gupta et al., Ribonuclease (RNAse) Protection Analysis
RNAse protection studies were carried out as previously described1996). Prior to treatment with cytokines, growth factor±dependent
cells were starved of these factors and serum for 4±5 hr. TF-1 cells (Melton et al., 1984). In brief, 10 mg of total RNA prepared by guanidi-
nium thiocyanate method was hybridized with A1, B1, and B2 ribo-were starved for 16 hr in 0.5% fetal calf serum. HepG2 cells were
treated with 200 U/ml of IL-6 (a generous gift from S. Chen-Kiang). probes (1±5 3 109 cpm/mg) in 80% formamide at 488C. After 16 hr,
hybridized products were digested with T2 RNAse (GIBCO/BRL),DA-3 and 32D and FdTrk cells were treated with recombinant murine
IL-3 (10 U/ml, Peprotech) and IFNg (66 U/ml, Peprotech) or with and protected products resolved on a 5% urea-acrylamide sequenc-
ing gel. A 220 bp murine antisense b-actin probe derived from pTRI-10% WEHI-conditioned media. TF-1 cells were stimulated with 50
U/ml GM-CSF (Schering-Plough). 293 cells were grown in Dulbec- b-Actin (Ambion) served as a positive control.
co's modified Eagle's medium /10% fetal calf serum. For transfec-
tion, 293 cells were pretreated with 25 mM chloroquine (Sigma) and Protein Assays
then transfected with 5 mg of the STAT5 constructs by the calcium Proteins were fractionated by SDS-PAGE with a 7% acrylamide
phosphate method (Pear et al., 1993). For STAT activation, 5 mg of resolving gel as previously described (Azam et al., 1995). For immu-
an erythropoietin receptor expression construct (a generous gift noblotting, proteins were transferred to nitrocellulose membranes
from H. Lodish [Klingmueller et al., 1995]) or granulocyte colony- and probed with antibodies at a 1:2000-fold dilution or as recom-
stimulating factor (G-CSF) chimeric receptor (I. S. and C. S., unpub- mended by the manufacturer (Pine et al., 1994). An assay for STAT5-
lished data) were cotransfected and stimulated with either 50 ng/ml cleaving activity was devised by preparing recombinant full-length
of Epo (Amgen) or 500 ng/ml of G-CSF (Amgen) for 30 min. STAT5b from SF9 cells (Yan et al., 1996). In brief, extracts were
prepared by sonication of SF9 cells 4 days after infection. Stat5b
was collected by oligonucleotide precipitation with a multimerizedDNA-Binding Assays and Cell Extracts
IRF-1 GAS element as previously reported (Rothman et al., 1994;The preparation and use of DNA oligonucleotide probes for mobility
Azam et al., 1995). These immobilized preparations of STAT5 wereshift assays has been previously described (Bonni et al., 1993; Pine
then incubated with DA-3, FdTrk, or Ba/F3 cell extracts preparedet al., 1994). Cytoplasmic,nuclear, or whole-cell extractswere made
by lysis with a CHAPS (3[(3-cholamidopropyl) dimethylammonio]-1-as previously described (Schindler et al., 1992; Eilers et al., 1993;
propane sulfonate, Sigma)±containing buffer (0.1% CHAPS, 10 mMPine et al., 1994). Next, 0.6 ml of STAT antibodies was added for 60
HEPES [pH 7.4], 2 mM EDTA, 5 mM DTT, 1 mg/ml aprotinin, 1 mg/min (at 48C) to 1±3 ml of extract prior to a standard shift reaction
ml leupeptin, and 5% glycerol [Nicholson et al., 1995]). This entailed(e.g., 20 min. at 258C in 12.5 ml). Oligonucleotide precipitation assays
the addition of 2 volumes of the CHAPS buffer to a pellet of 2 3were carried out as previously described (Rothman et al., 1994;
106 washed cells by gentle vortexing and a 1 hr 48C incubation.Azam et al., 1995). All shift reactions were done with the IRF-1 GAS
Subsequently, the lysate were cleared by centrifugation (12,000 3probe gatcGATTTCCCCGAAAT (Oligos Etc.).
g for 20 min at 48C). To assay for STAT5-cleaving activity, 20 ml of
the cleared lysate was added to 10 ml of immobilized STAT5b beads
and incubated for 1 hr at 378C. STAT5b was recovered by heatingAntibodies
in SDS-PAGE sample buffer and then resolving on SDS-PAGE.The pan-STAT5 antibody is a monoclonal antibody purchased from
Partial purification of this protease (M. A. and C. S., unpublishedTransduction Laboratories. The STAT5a antibodywas raised against
data) entailed sequential chromatography of FdTrk CHAPS extractsthe carboxy-terminal 15 amino acids of human STAT5a (St5aC15, a
on DEAE Sephacel (Pharmacia) and heparin agarose (Sigma). Prote-generous gift from T. Decker [Meinke et al., 1996]). Antibodies spe-
ase activity was eluted with a linear0±1 M NaCl gradientand assayedcific for the carboxy terminus of STAT5b were either purchased
as outlined above. Fractions with peak activity were pooled and(St5bC17, Santa Cruz Biotechnology) or prepared against a peptide
referred to as protease preparation-b (Pr-b) and protease prepara-encoding the carboxy-terminal 24 amino acids (St5bC24 [Mu et al.,
tion-a (Pr-a).1995]). The antiphosphotyrosine antibody (4G10) was purchased
from Upstate Biotechnology.
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